Company intelligence / Profile preview
SEEK
High Wycombe, United Kingdomseekacure.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company has HIV and Influenza vaccines in clinical trials, with HIV-v vaccine in Phase 1b and a universal flu vaccine (Flu-v) in Phase 1b/II trials. The HIV vaccine generates both B-cell and T-cell responses against conserved regions of the virus.
- Therapeutic areas
- PulmonologyMetabolic DisordersImmunologyOtherInfectious Diseases
- Modalities
- Peptide vaccinesImmunotherapeutics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Gador (for Chagas disease vaccine)Sosei Group Corporation
Beyond the preview
Go deeper on SEEK.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SEEK.